Eurofins Scientific SE
Eurofins Scientific SE ERFSF Peers
See (ERFSF) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ERFSF | $60.97 | -1.72% | 10.73B | 25.83 | $2.36 | +1.81% |
| LZAGY | $68.21 | -3.30% | 49.20B | 63.15 | $1.08 | +0.64% |
| LZAGF | $690.05 | -2.98% | 48.53B | 63.78 | $10.82 | +0.65% |
| WUXAY | $7.86 | +3.10% | 24.17B | 14.83 | $0.53 | +3.55% |
| WUXIF | $7.34 | N/A | 21.28B | 13.85 | $0.53 | +1.89% |
| BMXMF | $128.95 | N/A | 15.21B | 31.37 | $4.11 | +0.72% |
| SKHHY | $16.04 | -0.12% | 7.70B | 22.59 | $0.71 | +3.96% |
| SKHCF | $14.80 | N/A | 7.11B | 20.56 | $0.72 | +3.84% |
| DSRLF | $104.69 | -2.82% | 5.64B | 27.55 | $3.80 | +1.22% |
| HNGZY | $4.00 | N/A | 4.48B | 26.67 | $0.15 | +1.99% |
Stock Comparison
ERFSF vs LZAGY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, LZAGY has a market cap of 49.20B. Regarding current trading prices, ERFSF is priced at $60.97, while LZAGY trades at $68.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas LZAGY's P/E ratio is 63.15. In terms of profitability, ERFSF's ROE is +0.07%, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, ERFSF is more volatile compared to LZAGY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs LZAGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, LZAGF has a market cap of 48.53B. Regarding current trading prices, ERFSF is priced at $60.97, while LZAGF trades at $690.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas LZAGF's P/E ratio is 63.78. In terms of profitability, ERFSF's ROE is +0.07%, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, ERFSF is more volatile compared to LZAGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs WUXAY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, WUXAY has a market cap of 24.17B. Regarding current trading prices, ERFSF is priced at $60.97, while WUXAY trades at $7.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas WUXAY's P/E ratio is 14.83. In terms of profitability, ERFSF's ROE is +0.07%, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, ERFSF is more volatile compared to WUXAY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs WUXIF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, WUXIF has a market cap of 21.28B. Regarding current trading prices, ERFSF is priced at $60.97, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas WUXIF's P/E ratio is 13.85. In terms of profitability, ERFSF's ROE is +0.07%, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, ERFSF is more volatile compared to WUXIF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BMXMF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, BMXMF has a market cap of 15.21B. Regarding current trading prices, ERFSF is priced at $60.97, while BMXMF trades at $128.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas BMXMF's P/E ratio is 31.37. In terms of profitability, ERFSF's ROE is +0.07%, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, ERFSF is more volatile compared to BMXMF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SKHHY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, SKHHY has a market cap of 7.70B. Regarding current trading prices, ERFSF is priced at $60.97, while SKHHY trades at $16.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas SKHHY's P/E ratio is 22.59. In terms of profitability, ERFSF's ROE is +0.07%, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, ERFSF is more volatile compared to SKHHY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SKHCF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, SKHCF has a market cap of 7.11B. Regarding current trading prices, ERFSF is priced at $60.97, while SKHCF trades at $14.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas SKHCF's P/E ratio is 20.56. In terms of profitability, ERFSF's ROE is +0.07%, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, ERFSF is less volatile compared to SKHCF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DSRLF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, DSRLF has a market cap of 5.64B. Regarding current trading prices, ERFSF is priced at $60.97, while DSRLF trades at $104.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas DSRLF's P/E ratio is 27.55. In terms of profitability, ERFSF's ROE is +0.07%, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, ERFSF is more volatile compared to DSRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs HNGZY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, HNGZY has a market cap of 4.48B. Regarding current trading prices, ERFSF is priced at $60.97, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, ERFSF is more volatile compared to HNGZY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs VIMGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, VIMGF has a market cap of 1.81B. Regarding current trading prices, ERFSF is priced at $60.97, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas VIMGF's P/E ratio is 70.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, ERFSF is more volatile compared to VIMGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MRCHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, MRCHF has a market cap of 962.56M. Regarding current trading prices, ERFSF is priced at $60.97, while MRCHF trades at $16.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas MRCHF's P/E ratio is -99.65. In terms of profitability, ERFSF's ROE is +0.07%, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, ERFSF is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IDGXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, IDGXF has a market cap of 186.02M. Regarding current trading prices, ERFSF is priced at $60.97, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, ERFSF is more volatile compared to IDGXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ATLN Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, ATLN has a market cap of 186.00M. Regarding current trading prices, ERFSF is priced at $60.97, while ATLN trades at $2.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas ATLN's P/E ratio is -0.81. In terms of profitability, ERFSF's ROE is +0.07%, compared to ATLN's ROE of -19.68%. Regarding short-term risk, ERFSF is less volatile compared to ATLN. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs EDTXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, EDTXF has a market cap of 174.08M. Regarding current trading prices, ERFSF is priced at $60.97, while EDTXF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas EDTXF's P/E ratio is -15.26. In terms of profitability, ERFSF's ROE is +0.07%, compared to EDTXF's ROE of +0.61%. Regarding short-term risk, ERFSF is more volatile compared to EDTXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs AMCY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, AMCY has a market cap of 171.27M. Regarding current trading prices, ERFSF is priced at $60.97, while AMCY trades at $3.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas AMCY's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to AMCY's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to AMCY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs NNGRF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, NNGRF has a market cap of 164.30M. Regarding current trading prices, ERFSF is priced at $60.97, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, ERFSF's ROE is +0.07%, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, ERFSF is more volatile compared to NNGRF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CORBF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, CORBF has a market cap of 140.61M. Regarding current trading prices, ERFSF is priced at $60.97, while CORBF trades at $1.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas CORBF's P/E ratio is 2.92. In terms of profitability, ERFSF's ROE is +0.07%, compared to CORBF's ROE of +0.11%. Regarding short-term risk, ERFSF is more volatile compared to CORBF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs THOXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, THOXF has a market cap of 130.94M. Regarding current trading prices, ERFSF is priced at $60.97, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas THOXF's P/E ratio is -14.40. In terms of profitability, ERFSF's ROE is +0.07%, compared to THOXF's ROE of -0.91%. Regarding short-term risk, ERFSF is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DIUXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, DIUXF has a market cap of 115.49M. Regarding current trading prices, ERFSF is priced at $60.97, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, ERFSF's ROE is +0.07%, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, ERFSF is more volatile compared to DIUXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ANPCF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, ANPCF has a market cap of 99.98M. Regarding current trading prices, ERFSF is priced at $60.97, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, ERFSF's ROE is +0.07%, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, ERFSF is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs TIHE Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, TIHE has a market cap of 71.85M. Regarding current trading prices, ERFSF is priced at $60.97, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas TIHE's P/E ratio is 0.32. In terms of profitability, ERFSF's ROE is +0.07%, compared to TIHE's ROE of +0.01%. Regarding short-term risk, ERFSF is more volatile compared to TIHE. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BIOGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, BIOGF has a market cap of 65.41M. Regarding current trading prices, ERFSF is priced at $60.97, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, ERFSF is more volatile compared to BIOGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PCNEF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, PCNEF has a market cap of 63.00M. Regarding current trading prices, ERFSF is priced at $60.97, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, ERFSF's ROE is +0.07%, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, ERFSF is more volatile compared to PCNEF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PFGTF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, PFGTF has a market cap of 50.58M. Regarding current trading prices, ERFSF is priced at $60.97, while PFGTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas PFGTF's P/E ratio is -3.11. In terms of profitability, ERFSF's ROE is +0.07%, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, ERFSF is less volatile compared to PFGTF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BIOQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, BIOQ has a market cap of 42.46M. Regarding current trading prices, ERFSF is priced at $60.97, while BIOQ trades at $47.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas BIOQ's P/E ratio is 13.69. In terms of profitability, ERFSF's ROE is +0.07%, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, ERFSF is more volatile compared to BIOQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CLIFF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, CLIFF has a market cap of 29.65M. Regarding current trading prices, ERFSF is priced at $60.97, while CLIFF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas CLIFF's P/E ratio is -1.93. In terms of profitability, ERFSF's ROE is +0.07%, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, ERFSF is less volatile compared to CLIFF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ANPCY Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, ANPCY has a market cap of 27.08M. Regarding current trading prices, ERFSF is priced at $60.97, while ANPCY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas ANPCY's P/E ratio is -0.92. In terms of profitability, ERFSF's ROE is +0.07%, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, ERFSF is more volatile compared to ANPCY. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SNANF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, SNANF has a market cap of 25.05M. Regarding current trading prices, ERFSF is priced at $60.97, while SNANF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas SNANF's P/E ratio is -11.56. In terms of profitability, ERFSF's ROE is +0.07%, compared to SNANF's ROE of -2.51%. Regarding short-term risk, ERFSF is more volatile compared to SNANF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PMSNF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, PMSNF has a market cap of 23.61M. Regarding current trading prices, ERFSF is priced at $60.97, while PMSNF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas PMSNF's P/E ratio is -4.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, ERFSF is less volatile compared to PMSNF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs VILGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, VILGF has a market cap of 20.67M. Regarding current trading prices, ERFSF is priced at $60.97, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas VILGF's P/E ratio is -0.30. In terms of profitability, ERFSF's ROE is +0.07%, compared to VILGF's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to VILGF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IMMVF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, IMMVF has a market cap of 19.33M. Regarding current trading prices, ERFSF is priced at $60.97, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, ERFSF's ROE is +0.07%, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, ERFSF is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs LDXHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, LDXHF has a market cap of 18.71M. Regarding current trading prices, ERFSF is priced at $60.97, while LDXHF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas LDXHF's P/E ratio is -2.50. In terms of profitability, ERFSF's ROE is +0.07%, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, ERFSF is more volatile compared to LDXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs PCHM Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, PCHM has a market cap of 18.44M. Regarding current trading prices, ERFSF is priced at $60.97, while PCHM trades at $3.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas PCHM's P/E ratio is -0.02. In terms of profitability, ERFSF's ROE is +0.07%, compared to PCHM's ROE of +0.53%. Regarding short-term risk, ERFSF is more volatile compared to PCHM. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BMKDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, BMKDF has a market cap of 15.45M. Regarding current trading prices, ERFSF is priced at $60.97, while BMKDF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas BMKDF's P/E ratio is -17.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, ERFSF is less volatile compared to BMKDF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ABDXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, ABDXF has a market cap of 13.55M. Regarding current trading prices, ERFSF is priced at $60.97, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, ERFSF's ROE is +0.07%, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, ERFSF is more volatile compared to ABDXF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IZOZF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, IZOZF has a market cap of 12.11M. Regarding current trading prices, ERFSF is priced at $60.97, while IZOZF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas IZOZF's P/E ratio is -6.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, ERFSF is more volatile compared to IZOZF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MXDHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, MXDHF has a market cap of 8.65M. Regarding current trading prices, ERFSF is priced at $60.97, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, ERFSF's ROE is +0.07%, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, ERFSF is more volatile compared to MXDHF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs VRCDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, VRCDF has a market cap of 7.28M. Regarding current trading prices, ERFSF is priced at $60.97, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, ERFSF is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs TDSGF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, TDSGF has a market cap of 7.09M. Regarding current trading prices, ERFSF is priced at $60.97, while TDSGF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas TDSGF's P/E ratio is -2.37. In terms of profitability, ERFSF's ROE is +0.07%, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, ERFSF is less volatile compared to TDSGF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SQIDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, SQIDF has a market cap of 6.07M. Regarding current trading prices, ERFSF is priced at $60.97, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, ERFSF's ROE is +0.07%, compared to SQIDF's ROE of +0.00%. Regarding short-term risk, ERFSF is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs GNTLF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, GNTLF has a market cap of 6.05M. Regarding current trading prices, ERFSF is priced at $60.97, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, ERFSF's ROE is +0.07%, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, ERFSF is more volatile compared to GNTLF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SLDX Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, SLDX has a market cap of 4.78M. Regarding current trading prices, ERFSF is priced at $60.97, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas SLDX's P/E ratio is -0.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to SLDX's ROE of +0.06%. Regarding short-term risk, ERFSF is less volatile compared to SLDX. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs RNVA Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, RNVA has a market cap of 4.31M. Regarding current trading prices, ERFSF is priced at $60.97, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas RNVA's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to RNVA's ROE of +0.23%. Regarding short-term risk, ERFSF is more volatile compared to RNVA. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs JMPHF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, JMPHF has a market cap of 4.15M. Regarding current trading prices, ERFSF is priced at $60.97, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, ERFSF's ROE is +0.07%, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, ERFSF is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs AVCRF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, AVCRF has a market cap of 3.78M. Regarding current trading prices, ERFSF is priced at $60.97, while AVCRF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas AVCRF's P/E ratio is -3.73. In terms of profitability, ERFSF's ROE is +0.07%, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, ERFSF is less volatile compared to AVCRF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IDXG Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, IDXG has a market cap of 3.58M. Regarding current trading prices, ERFSF is priced at $60.97, while IDXG trades at $0.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas IDXG's P/E ratio is 1.98. In terms of profitability, ERFSF's ROE is +0.07%, compared to IDXG's ROE of -0.66%. Regarding short-term risk, ERFSF is less volatile compared to IDXG. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SZLSF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, SZLSF has a market cap of 3.55M. Regarding current trading prices, ERFSF is priced at $60.97, while SZLSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas SZLSF's P/E ratio is -0.02. In terms of profitability, ERFSF's ROE is +0.07%, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, ERFSF is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IDTA Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, IDTA has a market cap of 3.03M. Regarding current trading prices, ERFSF is priced at $60.97, while IDTA trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas IDTA's P/E ratio is 7.50. In terms of profitability, ERFSF's ROE is +0.07%, compared to IDTA's ROE of +0.36%. Regarding short-term risk, ERFSF is more volatile compared to IDTA. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ICBU Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, ICBU has a market cap of 2.26M. Regarding current trading prices, ERFSF is priced at $60.97, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas ICBU's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to ICBU's ROE of +0.70%. Regarding short-term risk, ERFSF is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs RSHN Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, RSHN has a market cap of 1.63M. Regarding current trading prices, ERFSF is priced at $60.97, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas RSHN's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to RSHN's ROE of -5.42%. Regarding short-term risk, ERFSF is less volatile compared to RSHN. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IBXXF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, IBXXF has a market cap of 1.61M. Regarding current trading prices, ERFSF is priced at $60.97, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, ERFSF's ROE is +0.07%, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, ERFSF is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IVRO Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, IVRO has a market cap of 1.28M. Regarding current trading prices, ERFSF is priced at $60.97, while IVRO trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas IVRO's P/E ratio is -0.70. In terms of profitability, ERFSF's ROE is +0.07%, compared to IVRO's ROE of +0.08%. Regarding short-term risk, ERFSF is more volatile compared to IVRO. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DIGP Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, DIGP has a market cap of 1.09M. Regarding current trading prices, ERFSF is priced at $60.97, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas DIGP's P/E ratio is -1.04. In terms of profitability, ERFSF's ROE is +0.07%, compared to DIGP's ROE of +0.05%. Regarding short-term risk, ERFSF is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs SCRSF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, SCRSF has a market cap of 849801.00. Regarding current trading prices, ERFSF is priced at $60.97, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, ERFSF's ROE is +0.07%, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, ERFSF is more volatile compared to SCRSF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs EPGNF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, EPGNF has a market cap of 692790.00. Regarding current trading prices, ERFSF is priced at $60.97, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, ERFSF's ROE is +0.07%, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, ERFSF is more volatile compared to EPGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs NSTM Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, NSTM has a market cap of 468815.00. Regarding current trading prices, ERFSF is priced at $60.97, while NSTM trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas NSTM's P/E ratio is -0.14. In terms of profitability, ERFSF's ROE is +0.07%, compared to NSTM's ROE of +0.87%. Regarding short-term risk, ERFSF is less volatile compared to NSTM. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MBGNF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, MBGNF has a market cap of 172578.00. Regarding current trading prices, ERFSF is priced at $60.97, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, ERFSF is more volatile compared to MBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs NVTAQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, NVTAQ has a market cap of 85948.00. Regarding current trading prices, ERFSF is priced at $60.97, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to NVTAQ's ROE of +1.79%. Regarding short-term risk, ERFSF is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ARYC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, ARYC has a market cap of 79348.00. Regarding current trading prices, ERFSF is priced at $60.97, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas ARYC's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to ARYC's ROE of +0.55%. Regarding short-term risk, ERFSF is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs HCLC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, HCLC has a market cap of 73985.00. Regarding current trading prices, ERFSF is priced at $60.97, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas HCLC's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to HCLC's ROE of +0.11%. Regarding short-term risk, ERFSF is more volatile compared to HCLC. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MEDVF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, MEDVF has a market cap of 54038.00. Regarding current trading prices, ERFSF is priced at $60.97, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, ERFSF's ROE is +0.07%, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, ERFSF is more volatile compared to MEDVF. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CHHL Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, CHHL has a market cap of 37320.00. Regarding current trading prices, ERFSF is priced at $60.97, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas CHHL's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to CHHL's ROE of N/A. Regarding short-term risk, ERFSF is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs IHTI Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, IHTI has a market cap of 32514.00. Regarding current trading prices, ERFSF is priced at $60.97, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas IHTI's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to IHTI's ROE of +0.00%. Regarding short-term risk, ERFSF is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs MEDD Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, MEDD has a market cap of 31910.00. Regarding current trading prices, ERFSF is priced at $60.97, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas MEDD's P/E ratio is -0.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to MEDD's ROE of +0.74%. Regarding short-term risk, ERFSF is more volatile compared to MEDD. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CGNH Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, CGNH has a market cap of 24046.00. Regarding current trading prices, ERFSF is priced at $60.97, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas CGNH's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to CGNH's ROE of +1.41%. Regarding short-term risk, ERFSF is less volatile compared to CGNH. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs TOMDF Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, TOMDF has a market cap of 14081.00. Regarding current trading prices, ERFSF is priced at $60.97, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas TOMDF's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, ERFSF is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ABMC Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, ABMC has a market cap of 4810.00. Regarding current trading prices, ERFSF is priced at $60.97, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas ABMC's P/E ratio is 0.01. In terms of profitability, ERFSF's ROE is +0.07%, compared to ABMC's ROE of +0.86%. Regarding short-term risk, ERFSF is more volatile compared to ABMC. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs RGDXQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, RGDXQ has a market cap of 3880.00. Regarding current trading prices, ERFSF is priced at $60.97, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, ERFSF is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs GWHP Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, GWHP has a market cap of 1313.00. Regarding current trading prices, ERFSF is priced at $60.97, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas GWHP's P/E ratio is -0.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to GWHP's ROE of +0.00%. Regarding short-term risk, ERFSF is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs CYPS Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, CYPS has a market cap of 811.00. Regarding current trading prices, ERFSF is priced at $60.97, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas CYPS's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to CYPS's ROE of N/A. Regarding short-term risk, ERFSF is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs ROSGQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, ROSGQ has a market cap of 593.00. Regarding current trading prices, ERFSF is priced at $60.97, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to ROSGQ's ROE of N/A. Regarding short-term risk, ERFSF is more volatile compared to ROSGQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs BIOCQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, BIOCQ has a market cap of 263.00. Regarding current trading prices, ERFSF is priced at $60.97, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, ERFSF's ROE is +0.07%, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, ERFSF is more volatile compared to BIOCQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs HTGMQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, HTGMQ has a market cap of 221.00. Regarding current trading prices, ERFSF is priced at $60.97, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, ERFSF is more volatile compared to HTGMQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs DMTKQ Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, DMTKQ has a market cap of 35.00. Regarding current trading prices, ERFSF is priced at $60.97, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, ERFSF is more volatile compared to DMTKQ. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.
ERFSF vs OPGX Comparison
ERFSF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ERFSF stands at 10.73B. In comparison, OPGX has a market cap of 17.00. Regarding current trading prices, ERFSF is priced at $60.97, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ERFSF currently has a P/E ratio of 25.83, whereas OPGX's P/E ratio is N/A. In terms of profitability, ERFSF's ROE is +0.07%, compared to OPGX's ROE of +0.46%. Regarding short-term risk, ERFSF is more volatile compared to OPGX. This indicates potentially higher risk in terms of short-term price fluctuations for ERFSF.